What is Ixazomib (MLN9708)?

Category: Others

Most popular types: Multiple Myeloma Phase I MLN9708 Trial


Ixazomib (MLN9708) is a type of cancer drug called a proteasome inhibitor. Cancer cells depend on proteasomes for growth. Ixazomib disrupts a cancer cells’ ability to survive by blocking the proteasome.

No patients have reported taking Ixazomib (MLN9708).
Last updated:
There are no evaluations for Ixazomib (MLN9708).